Home
News
Interviews
Companies
Videos
Markets
Subscribe
The
Latest
The Latest
News
Core One’s Dr. Robert E.W. Hancock to Host Virtual Townhall Webcast and Present on Proprietary Biosynthesized Psilocybin Wednesday, August 4, 2021
News
Braxia Scientific Provides Corporate Update and Reports Fiscal Fourth Quarter and Full-Year 2021 Financial Results
News
Novamind Opens 5th Clinic Location Specialized in Integrative Psychiatry for Patients with Treatment-Resistant Conditions
News
Tryp Therapeutics Announces Q3 2021 Financial Results
More Articles
FEATURED
Ketamine One Advances Research Capabilities via Controlled Substance Dealers Licence Application
News
Braxia Scientific CEO, Chief Medical Officer Awarded $918,000 by Canadian Government to Study Benefits of Integrating Ketamine with Cognitive Behavioural Therapy to Reduce Suicidality
News
MindMed Announces Initiation of Phase 1 Clinical Trial of Intravenous DMT
Trending
#
News
Cybin Announces Conditional Listing Approval from NYSE American
#
News
Levitee Labs to Commence Trading on the Canadian Securities Exchange Under the Ticker Symbol "LVT" on Wednesday, July 21st 2021
#
News
Tryp Therapeutics Announces Plans for Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan
#
Spotlight
Damon Michaels | Director, COO, & Co-Founder
#
News
Cybin Receives Final Approval to Commence Trading on the NYSE American on or About August 5
Companies
#
Tryp Therapeutics
NEO
NASDAQ
CSE
TSXV
Private Company
#
Cybin Corp
NEO
NASDAQ
CSE
TSXV
Private Company
#
Field Trip Health
NEO
NASDAQ
CSE
TSXV
Private Company
#
Numinus
NEO
NASDAQ
CSE
TSXV
Private Company
#
Mydecine Innovations Group
NEO
NASDAQ
CSE
TSXV
Private Company
